Search PubMed⌕ Search

Biomedical subjects

R Masteiková

Publications and source records attributed to R Masteiková.

6 recordsLinked to original sources

[Pharmaceutical hydrophilic gels].

From the pharmacopoeial standpoint, gels, together with ointments, creams, pastes, cataplasmata, and medicated plasters, rank among the group of topical semisolid preparations applied to the skin. They are bicoherent systems composed of the internal phase made of a polymer producing a coherent three-dimensional net-like structure, which fixes the liquid vehicle as the external phase. Intermolecular forces bind the molecules of the solvent to a polymeric net, thus decreasing the mobility of these molecules and producing a structured system with increased viscosity. The physical and chemical bonds binding the particles of the internal phase provide a relatively stable structure, which can originate by swelling of solid polymers, or by decreasing the solubility of the polymer in a solution. An important group of gels used in pharmacy are hydrophylic gels, or hydrogels, usually made of hydrophyilc polymers, which under certain conditions and polymer concentration, jellify. Attention of pharmaceutical research now concentrates primarily on hydrophilic gels, as this dosage form seems to be prospective for the development of modern drugs based on systems with prolonged and controlled release of active ingredients.

Biocompatible Materials↗

[Composite tincture from the tops of the purple coneflower (Echinacea purpurea) and the fruits of the dog rose (Rosa canina): technology of production and evaluation of quality].

This paper aimed to elaborate the technology of the production of a composite tincture with an immunostimulatory and adaptogenic effect, to select suitable methods of quality evaluation, and perform stability tests. The tops of the purple coneflower (Echinaceae herba) and fruits of the dog rose (Cynosbati fructus) in a ratio of 1:1 were employed to prepare the tincture. The tincture itself was prepared in a ratio of 1:5. The experiment revealed that ethanol 50% was the most suitable extracting agent. The optimal conditions for the obtaining of a quality tincture are formed when the drug is disintegrated into the required degree by grinding, percolation is used for extraction, and the rate of flowing of the extract from the percolator is 0.2 ml/min/100g of the drug. The determination of the dry residue, relative density, ethanol concentration and content of cichoric acid (spectrophotometrically), ascorbic acid (oxidimetrically), and tannins (manganometrically) served to evaluate the quality of prepared extracts. Stability tests (temperature 25+/-2 degrees C, relative humidity 60+/-5%, period of 2 years) have shown that the prepared tincture maintains its quality parameters for the given period.

Chemistry, Pharmaceutical↗

[Selection of an extraction agent and development of the technology for producing an extract with sedative effects].

The drugs Valerinae radix, Crataegi fructus, Leonuri herba and Melissae folium were used to produce a liquid plant extract. The experiment revealed that the extraction with 70% ethanol achieved the highest concentration of extractable active principles. The optimal conditions for obtaining a sedative extract are established when the method of repercolation is used, and in the production itself the batch of the drug is divided into equally large doses and a pre-prepared mixture of plant drugs is extracted. The extract prepared by this manner remains stable for the whole period of storage, i.e., 24 months.

Chemistry, Pharmaceutical↗

[Biological availability of ophthalmic drugs. 1. Increasing drug permeability in the cornea].

Most eye diseases are treated by topical administration of ophthalmic preparations. Low ophthalmic bioavailability is due to a number of physiological and physicochemical factors. The main obstacle to the penetration of active ingredients to the eye is the layered character of the cornea. Formulation of ophthalmic preparations enabling easier penetration of this biological barrier thus ranks among the most effective ways of improving bioavailability. Penetrability of the cornea can be increased by the following methods: a) adjustment of the actual acidity in such a way that pH of the preparation makes it possible to produce the optimal portion of non-ionized particles; b) incorporation of absorption enhancers (non-ionic tensides, salts of bile acids, some antimicrobial substances, EDTA, cyclodextrins, etc.) into the composition of the preparation, and c) production of prodrugs or ionic pairs.

Absorption↗

[Biological availability of ophthalmic preparations. 2. Ophthalmic therapeutic systems].

Ophthalmic therapeutic systems, which rank among the drugs of the second and third generation, make possible prolonged and controlled drug release, or the introduction of the drug direct into the site of action (a specific eye tissue) with minimal distribution into the adjacent tissues. The group mainly consists of solid ophthalmic preparations, in a lesser extent there are systems developed from hydrogels, colloidal carriers, etc. The present review lists both insoluble ophthalmic therapeutic systems and those soluble in water (degradable, erodible). Insoluble systems include membrane-controlled ophthalmic therapeutic systems (e.g. Ocusert), therapeutic eye lenses, eye implants, and other insoluble preparations. In the group of soluble preparations, topical inserts and systems are described, which are introduced into eye tissues as implants or injections.

Biological Availability↗

[Two-phase semi-solid hydrophilic systems--hydrocreams].

Production of a drug of good quality in the form of a hydrocream presents a wide set of complex problems. Hydrocreams as emulsions of the o/w type form a structured system which consists of at least three phases, the dispersed, crystalline hydrated, and crystalline gel one. The loading operations of manufacturing procedures can negatively affect both the individual components and the complex structure of the hydrocream. Due attention must thus be paid to the formulation study which together with the conditions of manufacture will ensure the production of a drug with required quality indices.

Drug Compounding↗